These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 18025261

  • 1. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
    Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Domany E, Galun E, Goldenberg D.
    Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
    [Abstract] [Full Text] [Related]

  • 2. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
    Katzenellenbogen M, Pappo O, Barash H, Klopstock N, Mizrahi L, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Mitchell LA, Kohen R, Domany E, Galun E, Goldenberg D.
    Cancer Res; 2006 Apr 15; 66(8):4001-10. PubMed ID: 16618719
    [Abstract] [Full Text] [Related]

  • 3. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver.
    Ella E, Heim D, Stoyanov E, Harari-Steinfeld R, Steinfeld I, Pappo O, Perlman TS, Nachmansson N, Rivkin L, Olam D, Abramovitch R, Wege H, Galun E, Goldenberg D.
    Oncotarget; 2014 Nov 15; 5(21):10318-31. PubMed ID: 25401338
    [Abstract] [Full Text] [Related]

  • 4. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ, Li C, Zhou XJ, Guan HG, Qin L, Li P, Wang ZW, Qian HX.
    J Gastroenterol Hepatol; 2008 Sep 15; 23(9):1448-58. PubMed ID: 17683489
    [Abstract] [Full Text] [Related]

  • 5. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X, Zhang H, Zhou X, Wang C, Zhang H, Zhang X, Ye L.
    Transl Res; 2007 Nov 15; 150(5):281-94. PubMed ID: 17964517
    [Abstract] [Full Text] [Related]

  • 6. Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis.
    Potikha T, Stoyanov E, Pappo O, Frolov A, Mizrahi L, Olam D, Shnitzer-Perlman T, Weiss I, Barashi N, Peled A, Sass G, Tiegs G, Poirier F, Rabinovich GA, Galun E, Goldenberg D.
    Hepatology; 2013 Jul 15; 58(1):192-204. PubMed ID: 23423643
    [Abstract] [Full Text] [Related]

  • 7. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
    Pasquinelli C, Bhavani K, Chisari FV.
    Cancer Res; 1992 May 15; 52(10):2823-9. PubMed ID: 1316229
    [Abstract] [Full Text] [Related]

  • 8. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP, Zhou HJ, Chen XP, Ren GY, Ruan XX, Zhang Y, Zhang RL, Chen J.
    J Exp Clin Cancer Res; 2007 Mar 15; 26(1):117-24. PubMed ID: 17550140
    [Abstract] [Full Text] [Related]

  • 9. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL.
    Gastroenterology; 2006 Dec 15; 131(6):1758-67. PubMed ID: 17087938
    [Abstract] [Full Text] [Related]

  • 10. Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis.
    Yamamoto M, Tamakawa S, Yoshie M, Yaginuma Y, Ogawa K.
    Mol Carcinog; 2006 Dec 15; 45(12):901-13. PubMed ID: 17013836
    [Abstract] [Full Text] [Related]

  • 11. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.
    Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, Nanney LB, Shyr Y, Beauchamp RD.
    Cancer Res; 2001 Jul 15; 61(14):5389-95. PubMed ID: 11454681
    [Abstract] [Full Text] [Related]

  • 12. Proteomic mining in the dysplastic liver of WHV/c-myc mice--insights and indicators for early hepatocarcinogenesis.
    Liu Y, Li C, Xing Z, Yuan X, Wu Y, Xu M, Tu K, Li Q, Wu C, Zhao M, Zeng R.
    FEBS J; 2010 Oct 15; 277(19):4039-53. PubMed ID: 20807235
    [Abstract] [Full Text] [Related]

  • 13. Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma.
    Riou P, Saffroy R, Comoy J, Gross-Goupil M, Thiéry JP, Emile JF, Azoulay D, Piatier-Tonneau D, Lemoine A, Debuire B.
    Clin Cancer Res; 2002 Oct 15; 8(10):3178-86. PubMed ID: 12374686
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations.
    Yamamoto Y, Sakamoto M, Fujii G, Tsuiji H, Kenetaka K, Asaka M, Hirohashi S.
    Hepatology; 2003 Mar 15; 37(3):528-33. PubMed ID: 12601349
    [Abstract] [Full Text] [Related]

  • 15. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression.
    Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P, Nussbaum T, Caselmann WH, Haab BB, Schirmacher P.
    Cancer Res; 2004 Sep 01; 64(17):6058-64. PubMed ID: 15342387
    [Abstract] [Full Text] [Related]

  • 16. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
    van Hengel J, D'Hooge P, Hooghe B, Wu X, Libbrecht L, De Vos R, Quondamatteo F, Klempt M, Brakebusch C, van Roy F.
    Gastroenterology; 2008 Mar 01; 134(3):781-92. PubMed ID: 18325391
    [Abstract] [Full Text] [Related]

  • 17. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ, Castillo J, Latasa MU, Goñi S, Segura V, Sangro B, Prieto J, Avila MA, Berasain C.
    Cancer Res; 2009 Feb 15; 69(4):1358-67. PubMed ID: 19190340
    [Abstract] [Full Text] [Related]

  • 18. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.
    Merle P, Kim M, Herrmann M, Gupte A, Lefrançois L, Califano S, Trépo C, Tanaka S, Vitvitski L, de la Monte S, Wands JR.
    J Hepatol; 2005 Nov 15; 43(5):854-62. PubMed ID: 16098625
    [Abstract] [Full Text] [Related]

  • 19. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
    Gamaev L, Mizrahi L, Friehmann T, Rosenberg N, Pappo O, Olam D, Zeira E, Bahar Halpern K, Caruso S, Zucman-Rossi J, Axelrod JH, Galun E, Goldenberg DS.
    Oncogene; 2021 Jan 15; 40(1):127-139. PubMed ID: 33093654
    [Abstract] [Full Text] [Related]

  • 20. Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic.
    Liu J, Xie Y, Ward JM, Diwan BA, Waalkes MP.
    Toxicol Sci; 2004 Feb 15; 77(2):249-57. PubMed ID: 14691202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.